For Queries or Clarification contact :

Kenya iTARA Data Summary (as of 2026-02-05)

Below is a summary of the iTARA Data and Plots which highlights the main data points of the study.

  • Recruiting sites 3 : Rhodes, Karen & Riruta

Total Number of Participants Screened in the Study.

screen_phc_ke n percent
Rhodes 781 56.8%
Karen 368 26.8%
Riruta 226 16.4%
Total 1375 100.0%

Participants Gender & Site Data

screen_phc_ke Female Male
Rhodes 43.1% (337) 56.9% (444)
Karen 53.5% (197) 46.5% (171)
Riruta 59.7% (135) 40.3% (91)
Total 48.7% (669) 51.3% (706)

The table below show the total number of participnats screened this week

screen_phc_ke n percent
Rhodes 17 43.6%
Karen 12 30.8%
Riruta 10 25.6%
Total 39 100.0%

Screening Eligibility

screen_eligible_conf Rhodes Karen Riruta Total
Yes 146 108 56 310
No 635 260 170 1065

The table below show the total number of participants screened, eligible and those not eligible this week

screen_eligible_conf Rhodes Karen Riruta Total
Yes 1 3 5 9
No 16 9 5 30

ELigible and Consented partcipants

screen_consent_yn Rhodes Karen Riruta Total
Yes 146 99 49 294
No 0 9 20 29
NA 635 260 157 1052

Removed all NAs from the data above

screened$screen_consent_yn n percent
Yes 294 91.0%
No 29 9.0%
Total 323 -

The table below show the total number of participnats consented to the study this week

screen_consent_yn Rhodes Karen Riruta Total
Yes 1 2 5 8
No 0 1 4 5
NA 16 9 1 26

Baseline Enrollment Summary Plots

  • Monthly Sites Participant Enrollment
  • Sites Participant Enrollment Against the Monthly Target
  • Monthly cumulative total participants enrollment. ## Xpert Data and Summary
enrol_phc_ke Positive Negative Trace Indeterminate No sputum
Rhodes 72 74 0 0 0
Karen 4 89 0 0 6
Riruta 13 36 0 0 0
Total 89 199 0 0 6
xpert_result n percent
Positive 89 30%
Negative 199 68%
Trace 0 0%
Indeterminate 0 0%
No sputum 6 2%
Total 294 -
Positive Negative Trace Indeterminate No sputum
Rhodes
49.3% (72) 50.7% (74) 0.0% (0) 0.0% (0) 0.0% (0)
Karen
4.0% (4) 89.9% (89) 0.0% (0) 0.0% (0) 6.1% (6)
Riruta
26.5% (13) 73.5% (36) 0.0% (0) 0.0% (0) 0.0% (0)
Total
30.3% (89) 67.7% (199) 0.0% (0) 0.0% (0) 2.0% (6)

Xpert Summary and Plot of Results

Baseline Participants

enrol_phc_ke n percent
Rhodes 146 50.0%
Karen 99 30.0%
Riruta 49 20.0%
Total 294 100.0%

Weekly baseline Participants Number

enrol_phc_ke n percent
Rhodes 1 11.1%
Karen 2 22.2%
Riruta 6 66.7%
Total 9 100.0%

Cohort Participants

obs_phc_ke n percent
Rhodes 70 38.9%
Karen 79 43.9%
Riruta 31 17.2%
Total 180 100.0%

Weekly Cohort Participants

obs_phc_ke n percent
Rhodes 1 16.7%
Karen 2 33.3%
Riruta 3 50.0%
Total 6 100.0%

Site Cohort recruitment numbers over time

Monthly Site Cohort Enrollment bar plots

Monthly Sites cohort enrollment against the target

Monthly Cummulative Site Cohort Enrolment Against the Target.

Number of participant who have had 26 week follow up visit done

obs_phc_ke n
Rhodes 19
Karen 27
Total 46

Weekly 26 week follow up Summary (as of 2026-02-05)

obs_phc_ke n
Karen 3
Total 3

Participants Exited from the Study, (as of 2026-02-05)

Total Number of exited participants with reasons

exit_reason n
Completed all follow up (26 week visit and MGIT result feedback) 12
Study withdrawal 5
Lost to follow up (missed visit procedures completed) 6
Notified of participant death 4
Other 21
No longer eligible (baseline Xpert positive) 85
No longer eligible (baseline MGIT positive) 7
Total 140

Number of exited participants with Other reasons

exit_reason exit_reason_detail n
Other LAM positive results 1
Other LAM positive results 1
Other Missed baselines cohort visit within study window 1
Other Out of window period 3
Other Outside the window period 1
Other Outside the window period 7
Other Outside window period 1
Other Outside window period 1
Other Participant could not attend the baseline cohort visit within the study window 1
Other Participant realised she was pregnant 1
Other Participant urine lam turned positive 1
Other Participant was not feeling well during the window period of cohort enrollment 1
Other Work related matters 1
Total - 21

Updated Cohort list after participants Exit

Exited cohort participants

exit_reason n percent
Completed all follow up (26 week visit and MGIT result feedback) 12 36.4%
Study withdrawal 1 3.0%
Lost to follow up (missed visit procedures completed) 6 18.2%
Notified of participant death 4 12.1%
Other 3 9.1%
No longer eligible (baseline Xpert positive) 0 0.0%
Not selected for cohort 0 0.0%
No longer eligible (baseline MGIT positive) 7 21.2%
Total 33 100.0%

Exited cohort participants with Other Reasons

exit_reason exit_reason_detail n
Other LAM positive results 1
Other LAM positive results 1
Other Participant urine lam turned positive 1
Total - 3

Remaining Cohort Participants After exited participants

obs_phc_ke n
Rhodes 60
Karen 58
Riruta 29
Total 147